ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,061.82
-1.20%
US Tech 100
17,235.60
-1.68%
Dow Jones
37,735.11
-0.65%
Brent Oil
89.985
0.12%
Bitcoin
62,895.04
-0.83%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Maxcyte Inc (MXCT) Quote

Maxcyte Inc

Maxcyte Inc (MXCT)

MaxCyte Inc
315.00
0.00
(0.00%)
Closed April 16 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
315.00
Bid
310.00
Ask
320.00
Volume
0.00
0.00 Day's Range 0.00
172.50 52 Week Range 430.00
Market Cap
402.633M
Previous Close
315.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
26,121
Shares Outstanding
103,504,571
Dividend Yield
-
PE Ratio
-10.62
Earnings Per Share (EPS)
-0.37
Revenue
41.29M
Net Profit
-37.92M

About Maxcyte Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.maxcyte.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Maxcyte Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker MXCT. The last closing price for Maxcyte was 315p. Over the last year, Maxcyte shares have traded in a share price range of 172.50p to 430.00p.

Maxcyte currently has 103,504,571 shares outstanding. The market capitalization of Maxcyte is £402.63 million. Maxcyte has a price to earnings ratio (PE ratio) of -10.62.

MXCT Latest News

More News

MaxCyte, Inc. Notice of Results

MaxCyte, Inc. 10 April 2024   MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024   ROCKVILLE, MD, April 10, 2024 - MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...

April 10 2024
RNS Regulatory News

MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024

ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

April 10 2024
GlobeNewswire Inc.

MaxCyte, Inc. Total Voting Rights and Block Listing Return

MaxCyte, Inc. 03 April 2024   MaxCyte, Inc.   ("MaxCyte" or the "Company")   Total Voting Rights and Block Listing Return   ROCKVILLE, MD, April 3, 2024: MaxCyte, Inc., (Nasdaq: MXCT; LSE:...

April 03 2024
RNS Regulatory News

TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

April 02 2024
Alliance News

MaxCyte, Inc. Signing of Strategic Platform License

MaxCyte, Inc. 02 April 2024       MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)   Be Biopharma to use MaxCyte's...

April 02 2024
RNS Regulatory News

MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)

ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

April 02 2024
GlobeNewswire Inc.

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. 02 April 2024     MaxCyte, Inc. ("MaxCyte" or the "Company")   Exercise of options and PDMR dealing   ROCKVILLE, MD, April 2, 2024: MaxCyte Inc., (Nasdaq: MXCT; LSE: MXCT), a...

April 02 2024
RNS Regulatory News

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. 20 March 2024     MaxCyte, Inc. ("MaxCyte" or the "Company")   Grant of Options, RSUs and PSUs and PDMR Dealing   Rockville, Maryland - 20 March 2024: MaxCyte Inc., (NASDAQ:...

March 20 2024
RNS Regulatory News

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. 20 March 2024     MaxCyte, Inc. ("MaxCyte" or the "Company")   Grant of Options, RSUs and PSUs and PDMR Dealing   Rockville, Maryland - 20 March 2024: MaxCyte Inc., (NASDAQ:...

March 20 2024
RNS Regulatory News

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

kville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutic ...

March 13 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-15-4.5454545454533033031519853328.97669921DE
4-12.5-3.81679389313327.5357.531522123335.92300081DE
12-92.5-22.6993865031407.5410307.526121349.53112275DE
2682.535.4838709677232.542023038141357.29711572DE
52-107.5-25.4437869822422.5430172.531053336.08978568DE
156-535-62.94117647068501230172.567878675.4671233DE
260127.568187.5123010587430552.85522539DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 6.26
(134.46%)
44.34M
LGVNLongeveron Inc
$ 2.94
(73.96%)
57.1M
HUBCHub Cyber Security Ltd
$ 1.9499
(49.99%)
75.08M
SPCBSuperCom Ltd
$ 0.40
(44.93%)
127.58M
ONVOOrganovo Holdings Inc
$ 1.345
(33.16%)
53.79M
MRNSMarinus Pharmaceuticals Inc
$ 1.29
(-82.85%)
35.57M
NXTPNextPlay Technologies Inc
$ 0.20
(-56.52%)
30.41k
CSLRComplete Solaria Inc
$ 0.26
(-50.00%)
814.26k
SWVLSwvl Holdings Corporation
$ 8.10
(-38.96%)
312.72k
MOTSMotus GI Holdings Inc
$ 0.173
(-34.25%)
1.37M
SQQQProShares UltraPro Short QQQ
$ 11.445
(5.10%)
201.04M
SNGXSoligenix Inc
$ 0.4697
(21.65%)
134.51M
SPCBSuperCom Ltd
$ 0.40
(44.93%)
127.58M
NKLANikola Corporation
$ 0.6503
(-7.14%)
121.2M
JAGXJaguar Health Inc
$ 0.109
(20.71%)
115.11M

Discussion

View Full Feed
Ray_137 Ray_137 3 minutes ago
20: I think I heard Rozen saying our equity committee can go after retained assets, those assets are there. I think he did not say LIQUIDATING TRUST.
COOP
tnc26 tnc26 4 minutes ago
The more restricted shares the more is better. Been adding since .15s for weeks and no one wanted to buy when is low like in tge .15s area for so long but people love to fomo bit that's good for us long term investorsas the price will increase exponentially in the coming weeks and months as revenue
DFCO
gotmilk gotmilk 8 minutes ago
Use Listerine in the morning and at night.

Colon Cancer Linked to Mouth Bacteria

https://www.scientificamerican.com/article/colon-cancer-linked-to-mouth-bacteria/
.
Advocate77 Advocate77 12 minutes ago
At the 11:10 minute of January‘s investor update, Mark said that it was a conservative estimate that the Stellantis deals would be signed in the first half of 2024.

https://m.youtube.com/watch?v=5GgR-KvV6wI&pp=ygUHTmlvY29ycA%3D%3D

So, maybe once in the last 10 years one
NB
RealDutch RealDutch 20 minutes ago
Could you explain please how this works? The way I understand it there will be 2 series or RISO. One is our equity (the 77M RISO tokens that have been issued) and the other one is the token being offered to clients backed by Basmati Rice. How many kg is it now? Is the price the same or different? Or
ITUP
allezlOM allezlOM 20 minutes ago
For you 🥳: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company(here $DBMM) They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments. For example, if you c
DBMM
Drugdoctor Drugdoctor 21 minutes ago
Smith is always wrong, Here is what he said - Total Nonsense then and now--- Sheesh...

MrSmith18

Re: None

Monday, April 01, 2024 12:22:26 PM

Post#
170585
of 170997
Just like I said. GVSI is and will continue to bar
GVSI
dstock07734 dstock07734 24 minutes ago
This is the webpage from Institute for Immunology at Mainz. This is the core research of the institution. Does the description look familiar? The interesting part is that this webpage was setup on June 10, 2018 according to WayBackMachine and remains unchanged ever since. Don't be surprised if there
NWBO
bigstocksnbonds bigstocksnbonds 25 minutes ago
I see busy route!!
archilles archilles 27 minutes ago
OTCmarkets is much easier to deal with and it allows multiple extensions until the company files. Unlike the SEC, OTCmarkets will work with the company until it files. It is to the best interest of all parties that filing is done. I have confidence that Steve will get the job done.

ENZC
allezlOM allezlOM 27 minutes ago
$DBMM April 15, 2024 SEC FIlings 10-Q & Shareholder's Update
https://www.otcmarkets.com/filing/html?id=17450610&guid=msQ-kq652ghBWBh
https://www.dbmmgroup.com/shareholders-update-april-15-2024/
DBMM
fuagf fuagf 27 minutes ago
The Alcatraz of the Rockies - Florence houses male inmates in the federal prison system deemed the most dangerous
and in need of the tightest control, including prisoners whose escape would pose a serious threat to national security.
https://en.wikipedia.org/wiki/ADX_Florence#Functio
Wise Man Wise Man 31 minutes ago
Judge Lamberth refuses to reply to Sandra Thompson and her Wall Street law firm, when they submitted an unopposed motion for Judgment as a Matter of Law on Friday.
Story developing.
https://twitter.com/CarlosVignote/status/1780107960632434870?t=MXxrh5jmFRaAZ_HnD9TIqA&s=19
FNMA
Cosa Cosa 32 minutes ago
It's a new all time low, about 450 not 52. Invest with caution. High risk high reward or complete loss.
MCRB
spdpro spdpro 33 minutes ago
18:14 > In SVXY 50 @ 51.14 > small load >
see what happens > time to play the other side as I missed uvxy ramp > so be it >
tried to "sell / short " uvxy > Nope >none to be had (HTB) status
SVXY
dinogreeves dinogreeves 33 minutes ago
No such thing as bashers here in the OTC get paid. Major boards yes, but not OTC. Go to the Fraud and DD board and you will see someone lost his family and a full million dollars on "Swirling" calls.
SPZI
mining hound mining hound 40 minutes ago
Hellix’ incorporation in Alberta expired in 2016: (TEX Venture past company summary, search apps tmx Hellix Venture company summary—I can’t get a link to work here). Since there is trading, the corporation seems to exist. Iam not sure where is registration or headquarters is located now. There
HLLXF
trender18 trender18 40 minutes ago
In February 20, 2024, the Company issued a convertible promissory note in the amount of $187,852 to the Company’s CEO for the prepayment of the lease entered in February 2023 for three years from February 2023 to January 2026 for the property at 10 N Newnan Street, Jacksonville, FL 32202. In Februar
CSUI
dinogreeves dinogreeves 41 minutes ago
I am inclined to believe that Jab probably knew it already this morning, just wanted to see anyone else caught it. Posted 5:38 AM my time in the West Coast.
TGLO
Frog77 Frog77 44 minutes ago
Awesome! Good luck to you . It is a fun hobby

12 foot plant sounds like a dream


Cheers with weed




https://youtu.be/i9SdGSC8jQQ?si=VJzn2Ar8ovI0GNAD







.
MEDH
MEDH
Mr. C Mr. C 44 minutes ago
This is big, good stuff!
TGLO
fuagf fuagf 45 minutes ago
That used to be me too, up late, in the sack virtually never before midnight, one, two. That 20 years ago up all night couple of times a week. Then the mini-stroke, anti-clot tablets, shortness of breath and - lol - a time flip. Now get roughly seven hours (interrupted) somewhere roughly betwee
Mr. C Mr. C 46 minutes ago
I think so, that volume came out of nowhere really early in the day
TGLO
sentiment_stocks sentiment_stocks 47 minutes ago
Well I, for one, think your post offers a very good take on the current situation.. so thank you! :)
NWBO

Your Recent History

LSE
MXCT
Maxcyte
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved